Revanesse Versa, Revanesse Versa +

Implant, Dermal, For Aesthetic Use

FDA Premarket Approval P160042 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

The increase in syringe volume from 1. 0 ml to 1. 2 ml of revanesse versa and revanesse versa+

DeviceRevanesse Versa, Revanesse Versa +
Classification NameImplant, Dermal, For Aesthetic Use
Generic NameImplant, Dermal, For Aesthetic Use
ApplicantPROLLENIUM MEDICAL TECHNOLOGIES INC.
Date Received2018-05-29
Decision Date2019-03-15
PMAP160042
SupplementS004
Product CodeLMH
Advisory CommitteeGeneral & Plastic Surgery
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product Yes
Applicant Address PROLLENIUM MEDICAL TECHNOLOGIES INC. 138 Industrial Parkway North aurora L4G 4

Supplemental Filings

Supplement NumberDateSupplement Type
P160042Original Filing
S017 2021-10-05 135 Review Track For 30-day Notice
S016
S015 2021-03-17 Special (immediate Track)
S014
S013
S012 2020-07-15 Real-time Process
S011 2020-01-22 Real-time Process
S010
S009 2019-05-06 30-day Notice
S008
S007
S006
S005
S004 2018-05-29 Normal 180 Day Track
S003 2017-12-20 Normal 180 Day Track
S002
S001 2017-08-14 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
66980800001000 P160042 000
66980800001017 P160042 003
66980800001024 P160042 004
10669808003032 P160042 014

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.